These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 25956216

  • 1. Serologic profile and clinical markers of Sjögren syndrome in patients with rheumatoid arthritis.
    Oliveira HF, de Souza TR, Carvalho CN, Duarte A, Carvalho AT, Leão JC, Gueiros LA.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jun; 119(6):628-35. PubMed ID: 25956216
    [Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [Abstract] [Full Text] [Related]

  • 3. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
    Ryu HJ, Takeuchi F, Kuwata S, Kim YJ, Lee EY, Lee EB, Song YW.
    Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J, Labarre C, Meyer O, Sibilia J, Mariette X.
    Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
    [Abstract] [Full Text] [Related]

  • 8. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
    Shen R, Ren X, Jing R, Shen X, Chen J, Ju S, Yang C.
    Lab Med; 2015 Jan; 46(3):226-9. PubMed ID: 26199263
    [Abstract] [Full Text] [Related]

  • 9. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis].
    Cho SY, Kang SY, Lee HJ, Lee WI.
    Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 12. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 13. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].
    Jin YJ, Sun L, Yang L, Xing R, Liu XY.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec 18; 48(6):947-950. PubMed ID: 27987495
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N, Kawakami A, Tamai M, Fujikawa K, Arima K, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Eguchi K.
    J Rheumatol; 2009 Jan 18; 36(1):113-5. PubMed ID: 19132785
    [Abstract] [Full Text] [Related]

  • 16. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F, Çapkin E, Karkucak M, Yücel B, Sönmez M, Alver A, Kaklikkaya N, Tosun M, Alemdaroğlu E, Solak M.
    Int J Rheum Dis; 2012 Dec 18; 15(6):538-45. PubMed ID: 23253237
    [Abstract] [Full Text] [Related]

  • 17. Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis.
    Itty S, Pulido JS, Bakri SJ, Baratz KH, Matteson EL, Hodge DO.
    Trans Am Ophthalmol Soc; 2008 Dec 18; 106():75-81; discussion 81-3. PubMed ID: 19277223
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J, Goulvestre C, Bialé L, Avouac J, Wipff J, Job-Deslandre C, Batteux F, Dougados M, Kahan A, Allanore Y.
    J Rheumatol; 2014 Dec 18; 41(12):2395-402. PubMed ID: 25274898
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.